Patient attitudes toward novel glaucoma drug delivery approaches

Digital Journal of Ophthalmology : DJO
Benjamin B WangAngela V Turalba

Abstract

Understanding patients' attitudes toward novel therapeutic options can help guide providers in personalizing treatment regimens for glaucoma patients. This study aimed to determine factors associated with acceptance of new drug delivery options among glaucoma patients. A total of 199 patient volunteers participated in an interviewer-administered survey from June to August 2016 at the Glaucoma Service of Massachusetts Eye and Ear. The questionnaire was designed to determine acceptance of 6 drug delivery approaches: (1) triple combination eye drop, (2) microdose eye spray, (3) drug-eluting contact lens, (4) drug-eluting periocular ring insert, (5) injectable subconjunctival drug insert, and (6) injectable anterior chamber implant. Other factors analyzed included self-reported demographics, disease severity, and prior ocular history. The average respondent age was 63.2 ± 15.1 years; 48% were female. For approaches 1-6 listed above, overall acceptance rates were, respectively, 85%, 54%, 31%, 43%, 32%, and 30%. Patients with greater disease severity and prior incisional glaucoma surgery were more likely to pursue alternatives to traditional eye drops. There is limited acceptance of alternatives to traditional eye drop medications am...Continue Reading

Citations

Nov 10, 2020·Veterinary Ophthalmology·Paul E Miller, Joshua Seth Eaton
May 29, 2021·Journal of Glaucoma·Catherine Q ZhuManishi Desai
Sep 30, 2021·Seminars in Ophthalmology·Portia E Sirinek, Michael M Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Seminars in Ophthalmology
Joseph B CiolinoDaniel S Kohane
© 2022 Meta ULC. All rights reserved